株探米国株
英語
エドガーで原本を確認する
6-K 1 ea0252228-6k_sapiens.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the month of August 2025

 

Commission File Number 000-20181

 

SAPIENS INTERNATIONAL CORPORATION N.V.

(Translation of registrant’s name into English)

 

Azrieli Center

26 Harokmim St.

Holon, 5885800 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

 

 

 


 

CONTENTS

 

Exhibits

 

The following exhibit is furnished as part of this Form 6-K:

 

Exhibit     Description
99.1   Press release

 

1


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SAPIENS INTERNATIONAL CORPORATION N.V.
   
Date: August 13, 2025 By: /s/ Roni Giladi
    Name:  Roni Giladi
    Title: Chief Financial Officer

 

2

 

EX-99.1 2 ea025222801ex99-1_sapiens.htm PRESS RELEASE

Exhibit 99.1

 

 

Sapiens Reports Second Quarter 2025 Financial Results

 

Rochelle Park, NJ, August 13, 2025 – Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2025.

 

Summary Results for Second Quarter 2025 (USD in millions, except per share data)

 

    GAAP           Non-GAAP        
    Q2 2025     Q2 2024     % Change     Q2 2025     Q2 2024     % Change  
Revenue   $ 141.6     $ 136.8       3.5 %   $ 141.6     $ 136.8       3.5 %
Gross Profit   $ 61.9     $ 60.1       3.0 %   $ 64.8     $ 62.5       3.8 %
Gross Margin     43.7 %     43.9 %     -20 bps       45.8 %     45.7 %     10 bps  
Operating Income   $ 16.8     $ 21.9       -23.2 %   $ 23.1     $ 24.8       -7.1 %
Operating Margin     11.9 %     16.0 %     -410 bps       16.3 %     18.2 %     -190 bps  
Net Income (*)   $ 14.2     $ 18.6       -23.6 %   $ 19.3     $ 21.0       -8.2 %
Diluted EPS   $ 0.25     $ 0.33       -24.2 %   $ 0.34     $ 0.37       -8.1 %

 

(*) Attributable to Sapiens’ shareholders

 

Roni Al-Dor, President and CEO of Sapiens, stated, “In the second quarter of 2025, we continued to execute on our strategic priorities, securing new deals and strengthening customer relationships across our Life, P&C, and Reinsurance segments. Our insurance platform supports insurers in advancing digital transformation, improving operational efficiency, and adopting AI-driven innovation.”

 

Mr. Al-Dor continued, “During the quarter, we completed the acquisitions of Advantage Go and Candella, acquisitions that strengthen our P&C and Life growth. We reiterate our priority to continue platform innovation, increase cross-selling, accelerate cloud adoption, and expand the Life & Annuities business globally, all of which will serve as catalysts to accelerated growth in 2026.”

 

 


 

Quarterly Results Conference Call

 

Following our announcement that Sapiens has entered into a definitive agreement to be acquired by Advent, Sapiens will forgo its Q2 2025 Earnings Call scheduled for today.

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens’ financial condition and results of operations. The Company’s management uses these non-GAAP measures to compare the Company’s performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, and tax adjustments related to non-GAAP adjustments.

 

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

 

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Annual Recurring Revenue (“ARR”) as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions, which may not be the same as the timing and amount of revenue recognized. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

 

The Company defines Adjusted EBITDA as net profit, adjusted to stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

 

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

 

2 


 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global leader in intelligent insurance SaaS-based software solutions. With Sapiens’ robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. Our SaaS-based Solutions help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers’ compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success. For more information visit sapiens or follow us on LinkedIn 

 

Investor and Media Contact
Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Investor Relations, Sapiens
Mobile: +1 917-533-4782
Email: Yaffa.cohen-ifrah@sapiens.com

 

Investor Contact
Kimberly Rogers
Managing Director, Hayden IR
Phone: +1 541-904-5075
Email: kim@HaydenIR.com

 

Forward Looking Statements

 

Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

 

3 


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENT OF INCOME

U.S. dollars in thousands (except per share amounts)

 

    Three months ended     Six months ended  
    June 30,     June 30,  
    2025     2024     2025     2024  
    (unaudited)     (unaudited)     (unaudited)     (unaudited)  
                         
Revenue     141,602       136,800       277,707       271,049  
Cost of revenue     79,711       76,696       155,156       153,385  
                                 
Gross profit     61,891       60,104       122,551       117,664  
                                 
Operating expenses:                                
Research and development, net     18,833       16,809       35,109       33,330  
Selling, marketing, general and administrative     26,261       21,412       49,449       41,929  
Total operating expenses     45,094       38,221       84,558       75,259  
                                 
Operating income     16,797       21,883       37,993       42,405  
                                 
Financial and other (income) expenses, net     (1,270 )     (1,109 )     (2,600 )     (2,201 )
Taxes on income     3,681       4,375       8,173       8,488  
                                 
Net income     14,386       18,617       32,420       36,118  
                                 
Attributable to non-controlling interest     154       -       252       141  
                                 
Net income attributable to Sapiens’ shareholders     14,232       18,617       32,168       35,977  
                                 
Basic earnings per share     0.25       0.33       0.58       0.65  
                                 
Diluted earnings per share     0.25       0.33       0.57       0.64  
                                 
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)     55,897       55,797       55,892       55,771  
                                 
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)     56,070       56,163       56,042       56,072  

 

4 


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

 

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

    Three months ended     Six months ended  
    June 30,     June 30,  
    2025     2024     2025     2024  
    (unaudited)     (unaudited)     (unaudited)     (unaudited)  
                         
GAAP revenue     141,602       136,800       277,707       271,049  
Valuation adjustment on acquired deferred revenue     -       -       -       -  
Non-GAAP revenue     141,602       136,800       277,707       271,049  
                                 
GAAP gross profit     61,891       60,104       122,551       117,664  
Amortization of capitalized software     1,675       1,569       3,186       3,114  
Amortization of other intangible assets     1,272       808       2,096       2,587  
Non-GAAP gross profit     64,838       62,481       127,833       123,365  
                                 
GAAP operating income     16,797       21,883       37,993       42,405  
Gross profit adjustments     2,947       2,377       5,282       5,701  
Capitalization of software development     (1,788 )     (1,823 )     (3,730 )     (3,540 )
Amortization of other intangible assets     2,094       1,223       3,654       2,456  
Stock-based compensation     845       811       1,692       1,583  
Acquisition-related costs *)     2,182       365       2,743       494  
Non-GAAP operating income     23,077       24,836       47,634       49,099  
                                 
GAAP net income attributable to Sapiens’ shareholders     14,232       18,617       32,168       35,977  
Operating income adjustments     6,280       2,953       9,641       6,694  
Taxes on income     (1,207 )     (529 )     (1,825 )     (1,209 )
Non-GAAP net income attributable to Sapiens’ shareholders     19,305       21,041       39,984       41,462  

 

(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

 

5 


 

Adjusted EBITDA Calculation
U.S. dollars in thousands

 

    Three months ended     Six months ended  
    June 30,     June 30,  
    2025     2024     2025     2024  
                         
GAAP operating profit     16,797       21,883       37,993       42,405  
                                 
Non-GAAP adjustments:                                
Amortization of capitalized software     1,675       1,569       3,186       3,114  
Amortization of other intangible assets     3,366       2,031       5,750       5,043  
Capitalization of software development     (1,788 )     (1,823 )     (3,730 )     (3,540 )
Stock-based compensation     845       811       1,692       1,583  
Compensation related to acquisition and acquisition-related costs     2,182       365       2,743       494  
                                 
Non-GAAP operating profit     23,077       24,836       47,634       49,099  
                                 
Depreciation     1,064       1,095       2,036       2,192  
Adjusted EBITDA     24,141       25,931       49,670       51,291  

 

Summary of NON-GAAP Financial Information
U.S. dollars in thousands (except per share amounts)

 

    Q2 2025     Q1 2025     Q4 2024     Q3 2024     Q2 2024  
                               
Revenues     141,602       136,105       134,305       137,025       136,800  
Gross profit     64,838       62,995       62,692       62,809       62,481  
Operating income     23,077       24,557       24,468       25,101       24,836  
Adjusted EBITDA     24,141       25,529       25,359       26,389       25,931  
Net income to Sapiens’ shareholders     19,305       20,679       20,710       21,091       21,041  
                                         
Diluted earnings per share     0.34       0.37       0.37       0.37       0.37  

 

Annual Recurring Revenue (“ARR”)

U.S. dollars in thousands 

 

    Three months ended  
    June 30,  
    2025     2024  
Annual Recurring Revenue     199,646       168,593  

 

Non-GAAP Revenues by Geographic Breakdown
U.S. dollars in thousands

 

    Q2 2025     Q1 2025     Q4 2024     Q3 2024     Q2 2024  
                               
North America     59,782       56,871       56,753       55,755       57,918  
Europe     70,095       67,480       65,624       69,281       66,072  
Rest of the World     11,725       11,754       11,928       11,989       12,810  
                                         
Total     141,602       136,105       134,305       137,025       136,800  

 

 

6 


 

Non-GAAP Revenue breakdown

 

U.S. dollars in thousands

 

    Three months ended     Six months ended  
    June 30,     June 30,  
    2025     2024     2025     2024  
                         
Software products and re-occurring post-production services (*)     109,859       98,044       217,916       192,285  
Pre-production implementation services (**)     31,743       38,756       59,791       78,764  
                                 
Total Revenues     141,602       136,800       277,707       271,049  

 

 

    Three months ended     Six months ended  
    June 30,     June 30,  
    2025     2024     2025     2024  
                         
Software products and re-occurring post-production services (*)     58,439       52,237       117,931       102,577  
Pre-production implementation services (**)     6,399       10,244       9,902       20,788  
                                 
Total Gross profit     64,838       62,481       127,833       123,365  

 

 

    Three months ended     Six months ended  
    June 30,     June 30,  
    2025     2024     2025     2024  
                         
Software products and re-occurring post-production services (*)   53.2 %   53.3 %   54.1 %   53.3 %
Pre-production implementation services (**)     20.2 %     26.4 %     16.6 %     26.4 %
                                 
Gross Margin     45.8 %     45.7 %     46.0 %     45.5 %

 

(*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance, cloud solutions and post-production services. This revenue stream is a mix of recurring and re-occurring in nature.

 

(**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

 

Adjusted Free Cash-Flow
U.S. dollars in thousands

 

    Q2 2025     Q1 2025     Q4 2024     Q3 2024     Q2 2024  
                               
Cash-flow from operating activities     1,873       25,353       42,109       13,083       8,545  
Increase in capitalized software development costs     (1,788 )     (1,942 )     (1,759 )     (1,834 )     (1,823 )
Capital expenditures     (1,003 )     (366 )     (419 )     (1,125 )     (666 )
Free cash-flow     (918 )     23,045       39,931       10,124       6,056  
                                         
Cash payments attributed to acquisition-related costs(*) (**)     626       -       1,238       124       134  
                                         
Adjusted free cash-flow     (292 )     23,045       41,169       10,248       6,190  

 

(*) Included in cash-flow from operating activities

 

(**) Acquisition-related payments pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

 

 

7 


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEET

U.S. dollars in thousands

 

    June 30,     December 31,  
    2025     2024  
    (unaudited)     (unaudited)  
             
ASSETS                
                 
CURRENT ASSETS                
Cash and cash equivalents     64,541       163,690  
Short-term bank deposit     10,000       52,500  
Trade receivables, net and unbilled receivables     134,949       99,603  
Other receivables and prepaid expenses     30,334       19,350  
Total current assets     239,824       335,143  
                 
LONG-TERM ASSETS                
Property and equipment, net     11,195       10,656  
Severance pay fund     3,065       3,208  
Goodwill and intangible assets, net     439,166       302,472  
Operating lease right-of-use assets     22,766       20,746  
Other long-term assets     23,628       19,486  
                 
Total long-term assets     499,820       356,568  
                 
TOTAL ASSETS     739,644       691,711  
                 
LIABILITIES AND EQUITY                
                 
CURRENT LIABILITIES                
Trade payables     11,615       8,414  
Current maturities of Series B Debentures     19,804       19,796  
Accrued expenses and other liabilities     91,286       77,390  
Current maturities of operating lease liabilities     7,284       6,440  
Deferred revenue     44,697       37,543  
Total current liabilities     174,686       149,583  
                 
LONG-TERM LIABILITIES                
Series B Debentures, net of current maturities     -       19,792  
Deferred tax liabilities     13,710       6,899  
Other long-term liabilities     11,260       10,331  
Long-term operating lease liabilities     18,289       17,719  
Accrued severance pay     9,580       7,758  
Total long-term liabilities     52,839       62,499  
                 
REDEEMABLE NON-CONTROLLING INTEREST     13,809       -  
                 
EQUITY     498,310       479,629  
                 
TOTAL LIABILITIES AND EQUITY     739,644       691,711  

 

8 


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands

 

    For the six months ended
June 30,
 
    2025     2024  
    (unaudited)     (unaudited)  
Cash flows from operating activities:            
Net income     32,420       36,118  
Reconciliation of net income to net cash provided by operating activities:                
Depreciation of property and equipment     2,036       2,192  
Amortization of intangible assets and capitalized software     8,936       8,157  
Accretion of discount on Series B Debentures     12       22  
Capital (gain) loss from sale of property and equipment     1       (9 )
Stock-based compensation related to options issued to employees     1,692       1,583  
                 
Net changes in operating assets and liabilities, net of amount acquired:                
Increase in trade receivables, net and unbilled receivables     (13,047 )     (12,723 )
Decrease in deferred tax liabilities, net     (1,874 )     (1,428 )
Decrease in other operating assets     1,011       3,445  
Increase in trade payables     1,504       4,446  
Decrease in other operating liabilities     (8,290 )     (8,354 )
Increase (decrease) in deferred revenues     1,966       (6,587 )
Increase in accrued severance pay, net     859       171  
                 
Net cash provided by operating activities     27,226       27,033  
                 
Cash flows from investing activities:                
Purchase of property and equipment     (1,399 )     (1,146 )
Proceeds from deposits     42,390       12,136  
Proceeds from sale of property and equipment     27       14  
Payments for business acquisitions, net of cash acquired     (106,189 )     (375 )
Capitalized software development costs     (3,730 )     (3,540 )
                 
Net cash provided by (used in) investing activities     (68,901 )     7,089  
                 
Cash flows from financing activities:                
Proceeds from employee stock options exercised     -       98  
Distribution of dividend     (37,037 )     (15,635 )
Repayment of Series B Debenture     (19,796 )     (19,796 )
Acquisition deferred payment     (455 )     -  
Acquisition of non-controlling interest     -       (4,131 )
                 
Net cash used in financing activities     (57,288 )     (39,464 )
                 
Effect of exchange rate changes on cash and cash equivalents     (186 )     1,272  
                 
Decrease in cash and cash equivalents     (99,149 )     (4,070 )
Cash and cash equivalents at the beginning of period     163,690       126,716  
                 
Cash and cash equivalents at the end of period     64,541       122,646  

 

9 


 

Debentures Covenants

 

As of June 30, 2025, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

 

Covenant 1

 

§ Target shareholders’ equity (excluding non-controlling interest): above $120 million.
     
§ Actual shareholders’ equity (excluding non-controlling interest) equal to $498.3 million.

 

Covenant 2

 

§ Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company’s Series B Debentures) below 65%.
     
§ Actual ratio of net financial indebtedness to net capitalization equal to (12.25)%.

 

Covenant 3

 

§ Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
     
§ Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (0.54).

 

10